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We describe the multimodality treatment regimen of a 53-year-old man diagnosed with olfactory neuroblastoma (Kadish stage C)
in the right nasal cavity extending into the ethmoid sinus and across the cribriform plate. Endoscopic surgery for tumor resection
was followed by a combination of external beam radiotherapy and stereotactic radiosurgery boost with concurrent chemotherapy.
The novel combination of dual radiation therapies allowed for the preservation of the nearby optic structures while providing an
adequate dosage to a suﬃcient volume of the aﬄicted tissue.
1.Introduction
Olfactory neuroblastoma (ONB) is a rare, malignant tumor
of the olfactory epithelium. ONB has been reported in ap-
proximately 1000 cases since its ﬁrst description in 1924.
Because of its rarity, deﬁnitive treatment guidelines have
been limited in scope and depth, but there are still eﬀective
treatments for ONB. En-bloc resection combined with ra-
diotherapy has been described as the standard of care [1–
3]. Recent studies have shown positive outcomes for tumors
treated with endoscopic surgery and adjuvant stereotactic
radiosurgery as a minimally invasive treatment modality [4–
6]. We present a case of a high-grade ONB near the optic
structures treated with a modiﬁed combination therapy, en-
doscopicsurgeryfollowedbyconventionalradiotherapywith
radiosurgery boost and concurrent chemotherapy.
2. Case Presentation
In February 2009, a 53-year-old man presented to an
ENT clinic with increased nasal congestion, increased ear
plugging, postnasal drainage, bifrontal headaches, and nasal
crusting. A paranasal sinus CT scan showed a deviation of
the nasal septum to the left, opacity in the right frontal and
anterior ethmoids, and a mass in the right superior meatus.
Nasal endoscopy conﬁrmed the presence of an irregular
reddish mass in the right nasal cavity. The biopsy showed
nestsofuniformcellswithhighnuclear-to-cytoplasmicratio,
round to ovoid nuclei, and ﬁne chromatin. Synaptophysin
immunostaining revealed cytoplastic positivity in 100% of
the tumor cells, while chromogranin was negative. The
patient was diagnosed with ONB and referred to endoscopic
surgery.2 Case Reports in Medicine
AnMRIscanrevealeda15×23×46mmheterogeneously
enhancing mass within the right nasal cavity extending into
therightethmoidsinusandcrossingthecribriformplateinto
the right anterior cranial fossa. The mass remained extra-
axial.AmaxillofacialCTshowedasofttissuemasswithinthe
medial right nasal cavity extending superiorly into the eth-
moid air cells and crossing the cribriform plate. The tumor
was staged at Kadish C with no lymph node metastasis.
In March 2009, the patient underwent a bilateral func-
tional endoscopic sinus surgery: bilateral maxillary antros-
tomies, bilateral ethmoidectomies, right sphenoidotomy,
rightfrontalsinusotomy,andexcisionoftherightnasalmass.
Negative margins were not able to be attained. The patient
was then referred to postoperative radiotherapy.
In April 2009, MRI and PET/CT imaging showed no
evidence of gross residual disease within the nasal cavity,
but there was still concern of microscopic tumor cells. Adju-
vant radiation therapy with concurrent cisplatin weekly at
30mg/m2 wasprescribed.Astandardpostoperativeradiation
dose for ONB is 54–66Gy, but the tolerance of the optic
nerve,theopticchiasm,andthebrainstemislimitedto54Gy.
Because of the tumor bed location, damage to the optic
tract and chiasm would have been likely to occur if standard
radiotherapy doses were prescribed, and radiosurgery alone
could not be safely targeted to the full area of involvement.
Thus, daily intensity-modulated radiation therapy (IMRT)
to the larger area of microscopic disease concern was utilized
along with a Gamma Knife (GK) radiosurgery boost to the
central tumor bed. IMRT was prescribed at 50Gy over 25
treatments.TheGKprescriptionof8.0Gytothe50%isodose
line resulted in 100% coverage of the target at 8Gy with
excellent dose falloﬀ to the nearby optic structures. A total
58Gy (biologically equivalent to 66Gy) was delivered to the
tumor bed and 50Gy to the surrounding areas of concern for
subclinical disease.
At last known followup, twenty-one months after treat-
ment, the patient reported no neurological deﬁcits and no
reductioninvision.ACTscanrevealedasmall,postoperative
defect in the medial aspect of the cribriform plate. This
was unchanged from prior scans that showed decreased soft
tissue within the ethmoid cavity adjacent to the defect within
the ﬂoor of the anterior cranial fossa. No evidence of path-
ologic enhancement or progressive soft tissue masses was
observed. The patient was clinically well, aside from some
mild short-term memory loss and occasional self-limiting
headaches.
3. Discussion
Determining the optimal treatment regimen for ONB is
diﬃcult; the location of a tumor can complicate treatments
by limiting the opportunity for resection and radiotherapy
because of inﬁltration into nearby critical structures. Pre-
viously regarded treatments include combinations of open
surgery, chemotherapy, and radiotherapy. Since the advent
of endoscopic surgery for ONB, equal or better outcomes for
patients undergoing combined endoscopic surgery and GK
radiosurgery have been observed [4–8]. When comparing
endoscopic surgery to open surgery, a greater survival rate
has been found for endoscopic techniques although the
study did not distinguish among adjuvant treatments [6].
However, the scope of this treatment can sometimes be lim-
ited. For example, tumor invasion into the anterior cranial
fossa indicates an anterior craniotomy since endoscopic pro-
cedures are inadequate in this area [9]. Thus, combined
endoscopic surgery and stereotactic surgery treatments are
usually conﬁned to patients with early stage tumors [6]. But
advances in endoscopic tools and techniques have extended
the reach of endoscopic procedures, as demonstrated in this
report.
We present a unique case of curative therapy with vision
preservationbyutilizingGammaKnifetherapyasaradiation
boost. The unfortunate location of the patient’s tumor fos-
tered a need for creative treatments in order to preserve
vision while also maintaining high local tumor control. The
endoscopic procedure followed by combination radiation
therapy (consisting of IMRT and GK boost) is a unique
regimenthattreatsthetumorandalsopreservesnearbyoptic
structures. IMRT targets a wider area around the tumor bed
while staying under the radiation tolerance of the nearby
optic structures; the GK boost provides the focal dose es-
calation to the tumor bed with excellent dose falloﬀ to the
sensitive structures. Either IMRT or GK alone could not have
avoided these sensitive structures as eﬀectively or provided
the necessary volume coverage.
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